Literature DB >> 12428038

Outcome in juvenile dermatomyositis.

Vaidehi Chowdhary1, Anupam Wakhlu, Amita Agarwal, Ramnath Misra.   

Abstract

The clinical features, outcome and complications of juvenile dermatomyositis were studied in a tertiary care hospital by retrospective analysis of case records. Nineteen patients were treated over an 11-year period. Median age at diagnosis was 12 years (2.5-16 years). Median duration of disease prior to diagnosis was 12 months (2-96 months). Proximal muscle weakness was seen in all 19 cases, neck muscle weakness in 14, pharyngeal muscle involvement in 5 and respiratory muscle involvement in 3 cases. Heliotrope rash was seen in 9 and Gottrons rash in 8 patients. Myocarditis and GI bleed were seen in 1 each while interstitial lung disease was seen in 2 patients. All except one patient received prednisolone. Methotrexate was used in 13 and azathioprine in 3 patients. Eight patients are in complete remission (CR), 8 partial remission and 2 patients had no response. Complications were calcinosis in 5, contractures in 2, TB in 4 and pyogenic infections in 4 patients. Juvenile dermatomyositis needs to be recognised early and treated aggressively to improve outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12428038

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  7 in total

1.  Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil.

Authors:  Luciena Cegatto Martins Ortigosa; Vitor Manuel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

2.  Profile of Pediatric Idiopathic Inflammatory Myopathies from a Tertiary Care Center of Eastern India.

Authors:  Sumantra Sarkar; Tanushree Mondal; Arpan Saha; Rakesh Mondal; Supratim Datta
Journal:  Indian J Pediatr       Date:  2017-03-02       Impact factor: 1.967

3.  Acute Presentation of Juvenile Dermatomyositis with Subclinical Cardiac Involvement: A Rare Case.

Authors:  Rhythm Khera; Shrayash Khare; Shailendra Kumar Singh
Journal:  J Clin Diagn Res       Date:  2016-12-01

4.  Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India.

Authors:  Surjit Singh; Deepti Suri; Roosy Aulakh; Anju Gupta; Amit Rawat; Rohit Manoj Kumar
Journal:  Clin Rheumatol       Date:  2014-07-23       Impact factor: 2.980

Review 5.  Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.

Authors:  Hobart W Walling; Pedram Gerami; Richard D Sontheimer
Journal:  Paediatr Drugs       Date:  2010       Impact factor: 3.022

6.  The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.

Authors:  Dragana Lazarevic; Angela Pistorio; Elena Palmisani; Paivi Miettunen; Angelo Ravelli; Clarissa Pilkington; Nico M Wulffraat; Clara Malattia; Stella Maris Garay; Michael Hofer; Pierre Quartier; Pavla Dolezalova; Inmaculada Calvo Penades; Virginia P L Ferriani; Gerd Ganser; Ozgur Kasapcopur; Jose Antonio Melo-Gomes; Ann M Reed; Malgorzata Wierzbowska; Lisa G Rider; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2012-06-26       Impact factor: 19.103

7.  Twelve years experience of juvenile dermatomyositis in North India.

Authors:  Surjit Singh; Arun Bansal
Journal:  Rheumatol Int       Date:  2005-09-15       Impact factor: 3.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.